Received: 28 July 2021
Accepted: 2 June 2022
First Online: 29 July 2022
: This work was undertaken as part of the COVID-19 Surveillance in Secondary School KIDs (sKIDsPLUS) and the protocol was approved by UKHSA Research Ethics Governance Group (reference Nr0228; 24 August 2020). Participants aged 16 and over, or their parent/guardians if under 16, provided informed consent online via SnapSurvey.
: Not applicable.
: MR reports that the Immunisation and Vaccine Preventable Diseases Division has provided vaccine manufacturers with post-marketing surveillance reports on pneumococcal and meningococcal infection which the companies are required to submit to the UK Licensing authority in compliance with their Risk Management Strategy. A cost recovery charge is made for these reports. All other authors have nothing to declare.